Trade CNTB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Connect Biopharma Holdings Limited (CNTB) is trading at US$1.28, down 0.78% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$148.62M. Over the past 52 weeks, CNTB has traded between US$1.06 and US$3.82. On Syfe you can trade CNTB with $0 commission and add it to your watchlist.
| Previous close | US$1.29 |
|---|---|
| Market cap | US$148.62M |
| 52-week range | US$1.06 – US$3.82 |
| Volume | 1.27M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in San Diego, CA.
Year: 2025
Oppenheimer Initiates Connect Biopharma at Outperform With $8 Price Target
Jul 9, 12:30 PM · MT Newswires
Connect Biopharma Completes Enrollment in Phase 2 Rademikibart Asthma Study
Jun 17, 1:31 PM · MT Newswires
Canaccord Genuity Initiates Connect Biopharma at Buy With $6 Price Target
May 26, 10:51 AM · MT Newswires
Connect Biopharma Holdings Limited (CNTB) stock is trading at US$1.28, -0.78% from the previous close of US$1.29.
The market cap for Connect Biopharma Holdings Limited (CNTB) stock is approximately US$148.62M.
The 52-week high for Connect Biopharma Holdings Limited (CNTB) stock is US$3.82.
The 52-week low for Connect Biopharma Holdings Limited (CNTB) stock is US$1.06.
Connect Biopharma Holdings Limited (CNTB) does not currently pay a dividend.
Stay on top of CNTB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
